Astec Lifesciences (BOM:533138) Buyback Yield % : 0.00 (As of May. 03, 2025)

View and export this data going back to 2009. Start your Free Trial

What is Astec Lifesciences Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Astec Lifesciences's current buyback yield was 0.00%.

Astec Lifesciences Buyback Yield % Historical Data

The historical data trend for Astec Lifesciences's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Astec Lifesciences Buyback Yield % Chart

Astec Lifesciences Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Buyback Yield %

Get a 7-Day Free Trial

-0.03

-0.01

Astec Lifesciences Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Buyback Yield %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Astec Lifesciences's Buyback Yield %

For the Agricultural Inputs subindustry, Astec Lifesciences's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Astec Lifesciences's Buyback Yield % Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Astec Lifesciences's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Astec Lifesciences's Buyback Yield % falls into.

Save Embed

;

Save Embed

;

Astec Lifesciences Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Astec Lifesciences's Buyback Yield for the fiscal year that ended in Mar. 2025 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (0	+	0.023)	/	13233.5028
	=	-0.00%

Astec Lifesciences's annualized Buyback Yield for the quarter that ended in Mar. 2025 is calculated as

Buyback Yield	=	Net Issuance of Stock		(TTM)		/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	(TTM)^**	/	Market Cap
	=	- (0	+	0.023)		/	13233.5028
	=	-0.00%

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Astec Lifesciences Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Astec Lifesciences's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Astec Lifesciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Astec Lifesciences Ltd (BOM:533138) » Definitions » Buyback Yield %

Comparable Companies

Traded in Other Exchanges

ASTEC:India

Address

Eastern Express Highway, Godrej One, 3rd Floor, Pirojshanagar, Vikhroli (East), Mumbai, MH, IND, 400 079

Website

https://www.godrejastec.com

Astec Lifesciences Ltd manufactures & distributes a wide range of Agrochemical active ingredients and pharmaceutical intermediates. The company's products include agrochemicals, such as Triazole Fungicides, Herbicides, and Insecticides. The company is also into Intermediates & Specialty chemicals. Geographically, all the operations of the firm function through India; however, its products are sold in the Indian and overseas markets. It operates in the business segment of Agrochemicals and has a business presence in India and outside India.

Astec Lifesciences Headlines

No Headlines